Is this you? Create Your Porfile
Avatar

Park John Edward

Boehringer Ingelheim

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Park John Edward is active.

Explore More

Publication

Featured researches published by Park John Edward.

Archive | 2017

3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt

Heckel Armin; Roth Gerald Jurgen; Grauert Matthias; Dahmann Georg; Park John Edward; Chaudhary Nveed; Brandl Trixi

Archive | 2017

Medikamenter for behandling eller forebygging av idiopatisk pulmonal fibrose

Heckel Armin; Roth Gerald Jurgen; Grauert Matthias; Dahmann Georg; Park John Edward; Chaudhary Nveed; Brandl Trixi

Archive | 2016

ΠΑΡΑΓΩΓΑ ΙΝΔΟΛΙΔΟΝΗΣ ΓΙΑ ΤΗΝ ΘΕΡΑΠΕΙΑ Ή ΠΡΟΛΗΨΗ ΙΝΩΤΙΚΩΝ ΑΣΘΕΝΕΙΩΝ

Park John Edward; Roth Gerald Jurgen; Heckel Armin; Chaudhary Nveed; Brandl Trixi; Dahmann Georg; Grauert Matthias

Archive | 2013

Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme

Roth Gerald Juergen; Heckel Armin; Chaudhary Nveed; Brandl Trixi; Dahmann Georg; Grauert Matthias; Park John Edward

Archive | 2011

Indolidone derivatives for the treatment or prevention of fibrotic diseases (vargatef, cryptogenic fibrosing alveolitis)

Park John Edward; Heckel Armin; Chaudhary Nveed; Brandl Trixi; Dahmann Georg; Grauert Matthias; Roth Gerald Juergen

Archive | 2011

USE OF 3-Z-[1-(4-(N-((4-METHYL-PIPERAZIN-1-YL)-METHYLCARBONYL)-N-METHYL-AMINO)-ANILINO)-1-PHENYL-METHYLENE]-6-METHOXYCARBONYL-2-INDOLINONE, OR THE TAUTOMERS, THE DIASTEREOMERS, THE ENANTIOMERS, THE MIXTURES THEREOF AND THE SALTS THEREOF AS MEDICAMENT FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Park John Edward; Roth Gerald Jurgen; Heckel Armin; Chaudhary Nveed; Brandl Trixi; Danmann Georg; Grauert Matthias

Archive | 2011

USE OF INDOLIDONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF IDIOPATHIC PULMONARY FIBROSIS

Park John Edward; Roth Gerald Juergen; Heckel Armin; Chaudhary Nveed; Brandl Trixi; Dahmann Georg; Grauert Matthias

Archive | 2009

Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme

Chaudhary Nveed; Roth Gerald Juergen; Heckel Armin; Lehmann-Lintz Thorsten; Kley Joerg; Park John Edward

Archive | 2009

MEDIKAMENTE ZUR BEHANDLUNG ODER PRÄVENTION FIBROTISCHER KRANKHEITEN

Park John Edward; Chaudhary Nveed; Lehmann-Lintz Thorsten; Heckel Armin; Roth Gerald Juergen; Kley Joerg; Brandl Trixi; Dahmann Georg; Grauert Matthias

Archive | 2009

medicamentos para o tratamento ou prevenÇço de doenÇas fibràticas

Park John Edward; Roth Gerald Juergen; Heckel Armin; Chaudhary Nveed; Dahmann Georg; Brandl Trixi; Grauert Matthias

Explore More

Collaboration

Dive into the Park John Edward's collaboration.

Top Co-Authors
Avatar

Chaudhary Nveed

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Heckel Armin

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Brandl Trixi

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Grauert Matthias

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Dahmann Georg

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Roth Gerald Juergen

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Lehmann-Lintz Thorsten

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Kley Joerg

Boehringer Ingelheim

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge